159 related articles for article (PubMed ID: 26096369)
1. Mifepristone by prescription: a dream in the United States but reality in Australia.
Grossman D; Goldstone P
Contraception; 2015 Sep; 92(3):186-9. PubMed ID: 26096369
[TBL] [Abstract][Full Text] [Related]
2. Medication abortion: Potential for improved patient access through pharmacies.
Raifman S; Orlando M; Rafie S; Grossman D
J Am Pharm Assoc (2003); 2018; 58(4):377-381. PubMed ID: 29752204
[TBL] [Abstract][Full Text] [Related]
3. If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion.
Gold M; Chong E
Contraception; 2015 Sep; 92(3):194-6. PubMed ID: 26093187
[TBL] [Abstract][Full Text] [Related]
4. Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone.
Ngoc NT; Blum J; Raghavan S; Nga NT; Dabash R; Diop A; Winikoff B
Contraception; 2011 May; 83(5):410-7. PubMed ID: 21477682
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
6. Pharmacists' experiences dispensing misoprostol and readiness to dispense mifepristone.
Ferketa M; Moore A; Klein-Barton J; Stulberg D; Hasselbacher L
J Am Pharm Assoc (2003); 2024; 64(1):245-252.e1. PubMed ID: 37913990
[TBL] [Abstract][Full Text] [Related]
7. The mifepristone-misoprostol regimen for early medical abortion.
Ellertson C; Waldman SN
Curr Womens Health Rep; 2001 Dec; 1(3):184-90. PubMed ID: 12112968
[TBL] [Abstract][Full Text] [Related]
8. Mifepristone+misoprostol vs. misoprostol alone for early medical abortion.
Ngo TD; Park MH
Contraception; 2012 Feb; 85(2):219; author reply 219-20. PubMed ID: 22067779
[No Abstract] [Full Text] [Related]
9. A two-stage increase in the dose of misoprostol improves the efficacy of medical abortion with mifepristone and prostaglandins.
Aubeny E
Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):54-5. PubMed ID: 11334477
[No Abstract] [Full Text] [Related]
10. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
[TBL] [Abstract][Full Text] [Related]
11. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
Lee RY; Moles R; Chaar B
Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial.
Raghavan S; Comendant R; Digol I; Ungureanu S; Dondiuc I; Turcanu S; Winikoff B
Contraception; 2010 Dec; 82(6):513-9. PubMed ID: 21074013
[TBL] [Abstract][Full Text] [Related]
13. Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia.
Louie KS; Chong E; Tsereteli T; Avagyan G; Abrahamyan R; Winikoff B
Eur J Contracept Reprod Health Care; 2017 Feb; 22(1):76-80. PubMed ID: 27871191
[TBL] [Abstract][Full Text] [Related]
14. A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S.
Chong E; Frye LJ; Castle J; Dean G; Kuehl L; Winikoff B
Contraception; 2015 Sep; 92(3):215-9. PubMed ID: 26142620
[TBL] [Abstract][Full Text] [Related]
15. Minimal effective dose of mifepristone for medical abortion.
Kapoor G; Salhan S; Sarda N; Aggarwal D
J Indian Med Assoc; 2014 Feb; 112(2):96-9. PubMed ID: 25935963
[TBL] [Abstract][Full Text] [Related]
16. Reaching women where they are: eliminating the initial in-person medical abortion visit.
Raymond EG; Grossman D; Wiebe E; Winikoff B
Contraception; 2015 Sep; 92(3):190-3. PubMed ID: 26134280
[TBL] [Abstract][Full Text] [Related]
17. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of mifepristone and buccal misoprostol versus buccal misoprostol alone for medical abortion.
Dahiya K; Ahuja K; Dhingra A; Duhan N; Nanda S
Arch Gynecol Obstet; 2012 Apr; 285(4):1055-8. PubMed ID: 22009509
[TBL] [Abstract][Full Text] [Related]
19. Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh.
Alam A; Bracken H; Johnston HB; Raghavan S; Islam N; Winikoff B; Reichenbach L
Int Perspect Sex Reprod Health; 2013 Jun; 39(2):79-87. PubMed ID: 23895884
[TBL] [Abstract][Full Text] [Related]
20. Early medical abortion: a new regimen up to 49 days' gestation.
Ashima T; Vinita A; Shalini R
Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):137-9. PubMed ID: 15760315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
